CDSCO UID IMP/IVD/2020/001094_f7d465c6106d92f7c1100e8e74b0b01a_1f35834edd682cddc538bcfd0079adca

C-Reactive Protein/Serum Amyloid A Reagent Kit

PTS Diagnostics India Private Limited·Device Class Class B·India CDSCO
Registration details
UID
IMP/IVD/2020/001094_f7d465c6106d92f7c1100e8e74b0b01a_1f35834edd682cddc538bcfd0079adca
Device class
Class B
Approving authority
CDSCO
Product information
The C-Reactive Protein / Serum Amyloid A Reagent Kit is intended to quantitatively determine the concentration of C-reactive protein ##PLACEHOLDER_0## and serum amyloid A ##PLACEHOLDER_0## in human serum. Clinically, the two indicators are mainly used as inflammatory markers
Other products from PTS Diagnostics India Private Limited
Products from the same license holder (10 products)
Arm Type Electronic Blood Pressure Monitor
Brand: Sinocare
Class B
C-Reactive Protein Reagent Kit
Class B
Urea/Creatinine/Uric Acid Reagent Kit
Class B
Alanine Aminotransferase/Aspartate Aminotransferase/Total Bilirubin/Albumin Reagent Kit
Class B
Beta-2-Microglobulin/Cystatin C Reagent Kit
Class B
Glycated Hemoglobin Reagent Kit
Brand: capillary
Class B
Blood Lipid Reagent Kit
Brand: capillary
Class B
1,5-Anhydro-D-Sorbitol Reagent Kit
Class B
APTT/PT/TT/FIB Reagent Kit
Brand: PT
Class C
Prothrombin Time Reagent Kit
Class C
About this record

C-Reactive Protein/Serum Amyloid A Reagent Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/001094_f7d465c6106d92f7c1100e8e74b0b01a_1f35834edd682cddc538bcfd0079adca. The license holder is PTS Diagnostics India Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.